Cerebrolysin is a standardized porcine brain-derived peptide mixture containing approximately 25% low-molecular-weight peptides and amino acids, including neurotrophic factors analogous to BDNF, NGF, CNTF, and GDNF. It is approved in multiple countries for stroke and dementia.